Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001140361-18-036244
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-13 16:38:27
Reporting Period:
2018-08-09
Accepted Time:
2018-08-13 16:38:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613859 Pra Health Sciences Inc. PRAH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1081714 R Henry Kravis C/o Kohlberg Kravis Roberts & Co. L.p.
9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1081715 R George Roberts C/o Kohlberg Kravis Roberts & Co. L.p.
2800 Sand Hill Road, Suite 200
Menlo Park CA 94025
No No No No
1404912 Kkr & Co. Inc. C/o Kohlberg Kravis Roberts & Co. L.p.
9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1472694 Kkr Management Llc C/o Kohlberg Kravis Roberts & Co. L.p.
9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1472697 Ltd Gp Holdings Fund Kkr C/o Kohlberg Kravis Roberts & Co. L.p.
9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1472698 L.p. Holdings Fund Kkr C/o Kohlberg Kravis Roberts & Co. L.p.
9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1743754 Kkr Group Holdings Corp. C/o Kohlberg Kravis Roberts & Co. L.p.
9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-08-09 6,500,000 $101.01 6,695,984 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
Footnotes
  1. This amount represents the secondary public offering price per share of common stock of PRA Health Sciences, Inc., less the underwriting discount of $0.49 per share.
  2. Securities are held by KKR PRA Investors L.P. KKR PRA Investors GP II LLC is the sole general partner of KKR PRA Investors L.P. KKR PRA Investors GP LLC is the sole member of KKR PRA Investors GP II LLC. KKR North America Fund XI L.P. is the sole member of KKR PRA Investors GP LLC. KKR Associates North America XI L.P. is the general partner of KKR North America Fund XI L.P. KKR North America XI Limited is the general partner of KKR Associates North America XI L.P. KKR Fund Holdings L.P. is the sole shareholder of KKR North America XI Limited. KKR Fund Holdings GP Limited is a general partner of KKR Fund Holdings L.P. KKR Group Holdings Corp. is a general partner of KKR Fund Holdings L.P. and the sole shareholder of KKR Fund Holdings GP Limited. KKR & Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR Management LLC is the controlling shareholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the designated members of KKR Management LLC.
  3. Each of the Reporting Persons (other than KKR PRA Investors L.P.), disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than KKR PRA Investors L.P.) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.